Trial Profile
Phase II proof-of-concept study of CT 327 in patients with pain
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2012
Price :
$35
*
At a glance
- Drugs Pegcantratinib (Primary)
- Indications Pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Creabilis SA
- 29 Feb 2012 Study is ongoing, according to a Creabilis media release.
- 05 Oct 2011 Study is ongoing according to a Creabilis media release.
- 16 Dec 2010 New trial record